BioCentury | Jul 13, 2020
Politics, Policy & Law

Cipla’s withdrawal of antibiotic marketing application latest sign of AMR market failure

...an antibiotic it acquired in a fire sale from Achaogen after the biotech declared bankruptcy. Cipla...
...and Achaogen hit a brick wall when it tried to market the product. Cipla Ltd. (NSE:CIPLA; BSE:CIPLA...
...CHMP, Cipla stated that “despite its best efforts thus far, at this point in time Cipla...
BioCentury | Jul 6, 2020
Product Development

U.K. may be near 60M dose deal with Sanofi, GSK for second COVID-19 vaccine partnership

...children hospitalized with severe disease. Last month, India approved injectable remdesivir formulations from Cipla Ltd. (NSE:CIPLA; BSE:CIPLA...
BioCentury | Jul 1, 2020
Emerging Company Profile

Engrail aims to build CNS pipeline by improving upon deprioritized assets

...class,” said Sudarsan, who was CEO of Cipla Technologies LLC, a unit of Cipla Ltd. (NSE:CIPLA; BSE:CIPLA...
BioCentury | Jun 26, 2020
Regulation

Data Bytes: CHMP’s June opinions

...VX-445/VX-661/VX-770) Turalio, pexidartinib (PLX3397) Xiidra, lifitegrast (SAR 1118, SHP606) Zemdri, plazomicin (achn-490) Gilead Sciences Inc. Acceleron Pharma Inc. Vertex Pharmaceuticals Inc. Novartis AG Cipla Ltd. Bristol...
BioCentury | Jun 26, 2020
Product Development

Gilead goes for lung delivery of remdesivir, earlier COVID-19 disease stage

...The authorization from India’s Drugs Standard Control Organization covers injectable remdesivir formulations from Cipla Ltd. (NSE:CIPLA; BSE:CIPLA...
BioCentury | May 13, 2020
Product Development

Gilead secures global access to remdesivir via generic manufacturing deals

...in 127 countries, nearly all low- and lower-middle income. The generic manufacturers are Cipla Ltd. (NSE:CIPLA; BSE:CIPLA...
BioCentury | Jul 17, 2019
Company News

July 16 Company Quick Takes: Mazumdar-Shaw, Mukherjee to bring CAR Ts to India; plus Cipla, Celgene, Novartis, Seattle Genetics

...Vor Biopharma Inc. Cipla re-enters China with JV The U.K. subsidiary of India-based Cipla Ltd. (NSE:CIPLA; BSE:CIPLA...
...Co. Ltd. (Jiangsu, China) to manufacture respiratory products. The JV will be a subsidiary of Cipla...
...stake, while Acebright will invest $8 million and hold a 20% stake. The JV marks Cipla's...
BioCentury | Jun 7, 2019
Company News

June 7 Company Quick Takes: Expanded label for PTC’s DMD drug; plus Achaogen, ICER on migraine and Nucala

...in April, plus royalties and assumption of certain liabilities. The U.S. subsidiary of Cipla Ltd. (NSE:CIPLA; BSE:CIPLA...
BioCentury | Feb 28, 2019
Company News

Cipla, Wellthy to offer digital disease management platform

...Cipla Ltd. (NSE:CIPLA) and Wellthy Therapeutics Pvt. Ltd. (Mumbai, India) partnered to offer digital disease management...
...Cipla Ltd. (BSE:CIPLA; NSE:CIPLA), Mumbai, India Wellthy Therapeutics Pvt. Ltd., Mumbai, India Business: Bioinformatics, Cardiovascular, Endocrine/Metabolic Shannon Lehnbeuter Cipla Ltd. Wellthy...
BioCentury | Dec 21, 2018
Financial News

New Rhein raises $47.7M towards debut fund

...M&A at Novartis AG (NYSE:NVS; SIX:NOVN). Saxena's past roles include global CEO of Cipla Ltd. (NSE:CIPLA; BSE:CIPLA...
Items per page:
1 - 10 of 61
BioCentury | Jul 13, 2020
Politics, Policy & Law

Cipla’s withdrawal of antibiotic marketing application latest sign of AMR market failure

...an antibiotic it acquired in a fire sale from Achaogen after the biotech declared bankruptcy. Cipla...
...and Achaogen hit a brick wall when it tried to market the product. Cipla Ltd. (NSE:CIPLA; BSE:CIPLA...
...CHMP, Cipla stated that “despite its best efforts thus far, at this point in time Cipla...
BioCentury | Jul 6, 2020
Product Development

U.K. may be near 60M dose deal with Sanofi, GSK for second COVID-19 vaccine partnership

...children hospitalized with severe disease. Last month, India approved injectable remdesivir formulations from Cipla Ltd. (NSE:CIPLA; BSE:CIPLA...
BioCentury | Jul 1, 2020
Emerging Company Profile

Engrail aims to build CNS pipeline by improving upon deprioritized assets

...class,” said Sudarsan, who was CEO of Cipla Technologies LLC, a unit of Cipla Ltd. (NSE:CIPLA; BSE:CIPLA...
BioCentury | Jun 26, 2020
Regulation

Data Bytes: CHMP’s June opinions

...VX-445/VX-661/VX-770) Turalio, pexidartinib (PLX3397) Xiidra, lifitegrast (SAR 1118, SHP606) Zemdri, plazomicin (achn-490) Gilead Sciences Inc. Acceleron Pharma Inc. Vertex Pharmaceuticals Inc. Novartis AG Cipla Ltd. Bristol...
BioCentury | Jun 26, 2020
Product Development

Gilead goes for lung delivery of remdesivir, earlier COVID-19 disease stage

...The authorization from India’s Drugs Standard Control Organization covers injectable remdesivir formulations from Cipla Ltd. (NSE:CIPLA; BSE:CIPLA...
BioCentury | May 13, 2020
Product Development

Gilead secures global access to remdesivir via generic manufacturing deals

...in 127 countries, nearly all low- and lower-middle income. The generic manufacturers are Cipla Ltd. (NSE:CIPLA; BSE:CIPLA...
BioCentury | Jul 17, 2019
Company News

July 16 Company Quick Takes: Mazumdar-Shaw, Mukherjee to bring CAR Ts to India; plus Cipla, Celgene, Novartis, Seattle Genetics

...Vor Biopharma Inc. Cipla re-enters China with JV The U.K. subsidiary of India-based Cipla Ltd. (NSE:CIPLA; BSE:CIPLA...
...Co. Ltd. (Jiangsu, China) to manufacture respiratory products. The JV will be a subsidiary of Cipla...
...stake, while Acebright will invest $8 million and hold a 20% stake. The JV marks Cipla's...
BioCentury | Jun 7, 2019
Company News

June 7 Company Quick Takes: Expanded label for PTC’s DMD drug; plus Achaogen, ICER on migraine and Nucala

...in April, plus royalties and assumption of certain liabilities. The U.S. subsidiary of Cipla Ltd. (NSE:CIPLA; BSE:CIPLA...
BioCentury | Feb 28, 2019
Company News

Cipla, Wellthy to offer digital disease management platform

...Cipla Ltd. (NSE:CIPLA) and Wellthy Therapeutics Pvt. Ltd. (Mumbai, India) partnered to offer digital disease management...
...Cipla Ltd. (BSE:CIPLA; NSE:CIPLA), Mumbai, India Wellthy Therapeutics Pvt. Ltd., Mumbai, India Business: Bioinformatics, Cardiovascular, Endocrine/Metabolic Shannon Lehnbeuter Cipla Ltd. Wellthy...
BioCentury | Dec 21, 2018
Financial News

New Rhein raises $47.7M towards debut fund

...M&A at Novartis AG (NYSE:NVS; SIX:NOVN). Saxena's past roles include global CEO of Cipla Ltd. (NSE:CIPLA; BSE:CIPLA...
Items per page:
1 - 10 of 61